PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15132991-9	2004	However, treatment with U0126 (known as the ERKs inhibitor) or wortmannin (known as the PI-3K inhibitor), but not SB203580 (known as the p38 MAPK inhibitor), markedly inhibited the expression of MMP-9 induced by HBx in HBx-transfected cells.	U 0126	24-29	X protein	Hepatitis B virus	212-215	
19912689-3	2009	RESULTS: ERK inhibitor U0126 inhibited the expression of the c-Met in HBx-transfected HepG2 cells.	U 0126	23-28	X protein	Hepatitis B virus	70-73	
19912689-5	2009	Furthermore, the ERK inhibitor U0126 also inhibited the invasiveness of HBX-transfected HepG2 cells.	U 0126	31-36	X protein	Hepatitis B virus	72-75	
15132991-9	2004	However, treatment with U0126 (known as the ERKs inhibitor) or wortmannin (known as the PI-3K inhibitor), but not SB203580 (known as the p38 MAPK inhibitor), markedly inhibited the expression of MMP-9 induced by HBx in HBx-transfected cells.	U 0126	24-29	X protein	Hepatitis B virus	219-222	
15132991-10	2004	Seemingly, the invasiveness of HBx-transfected cells was decreased by treating with U0126 or wortmannin, but not SB203580.	U 0126	84-89	X protein	Hepatitis B virus	31-34